Merck’s MRK strong foothold in the oncology space is propelled by its biggest revenue driver, Keytruda. The blockbuster PD-L1 ...

Health and Human Services Secretary Robert F. Kennedy Jr. has halted nearly half a billion dollars in funding for mRNA-based respiratory vaccines—and thereby ended America’s leadership research into ...

MRNA vaccines are "the most phenomenal medical breakthrough of the 21st century." And the excitement around them means a few grant cancellations—worth about $23 million per program, or less than 3% of ...

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...